These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2760620)
1. Postnatal development of cholecystokinin-like immunoreactivity and its mRNA level in rat brain regions. Takeda K; Koshimoto H; Uchiumi F; Haun RS; Dixon JE; Kato T J Neurochem; 1989 Sep; 53(3):772-8. PubMed ID: 2760620 [TBL] [Abstract][Full Text] [Related]
2. Developmental and regional changes of cholecystokinin mRNA in rat brains. Hasegawa M; Usui H; Araki K; Kuwano R; Takahashi Y FEBS Lett; 1986 Jan; 194(2):224-6. PubMed ID: 3940896 [TBL] [Abstract][Full Text] [Related]
3. Chemical kindling induced by pentylenetetrazol changes cholecystokinin mRNA and peptide levels in rat frontal cortex. Takeda K; Nakata K; Chikuma T; Ito T; Kato T Neurosci Lett; 1997 Oct; 234(2-3):115-8. PubMed ID: 9364511 [TBL] [Abstract][Full Text] [Related]
4. Bilateral ablation of frontal cortex reduces concentration of cholecystokinin-like immunoreactivity in rat dorsolateral striatum. Meyer DK; Schultheiss K; Hardung M Brain Res; 1988 Jun; 452(1-2):113-7. PubMed ID: 3401728 [TBL] [Abstract][Full Text] [Related]
5. Effect of pentylenetetrazol treatment on cholecystokinin mRNA and peptide levels in rat hippocampus and cortex. Takeda K; Nakata K; Takahashi S; Chikuma T; Kato T Brain Res; 1998 Jan; 779(1-2):320-3. PubMed ID: 9473710 [TBL] [Abstract][Full Text] [Related]
6. Developmental regulation of mRNAs encoding rat brain kainate/AMPA receptors: a northern analysis study. Durand GM; Zukin RS J Neurochem; 1993 Dec; 61(6):2239-46. PubMed ID: 8245974 [TBL] [Abstract][Full Text] [Related]
7. Expression of the cholecystokinin gene in rat brain during development. Duchemin AM; Quach TT; Iadarola MJ; Deschenes RJ; Schwartz JP; Wyatt RJ Dev Neurosci; 1987; 9(1):61-7. PubMed ID: 3595476 [TBL] [Abstract][Full Text] [Related]
8. Regional distribution of cholecystokinin messenger RNA in rat brain during development: quantitation and correlation with cholecystokinin immunoreactivity. De Belleroche J; Bandopadhyay R; King A; Malcolm AD; O'Brien K; Premi BP; Rashid A Neuropeptides; 1990 Apr; 15(4):201-12. PubMed ID: 2259392 [TBL] [Abstract][Full Text] [Related]
9. In vivo release of cholecystokinin-like immunoreactivity in rat frontal cortex under freely moving conditions. Takita M; Tsuruta T; Oh-hashi Y; Kato T Neurosci Lett; 1989 May; 100(1-3):249-53. PubMed ID: 2761773 [TBL] [Abstract][Full Text] [Related]
10. Transient increases and individual variations in preprocholecystokinin gene expression in rat telencephalic regions during postnatal development: a quantitative comparison between preprocholecystokinin mRNA and preproenkephalin mRNA. Yoshikawa K; Aizawa T Brain Res; 1988 Sep; 464(2):87-96. PubMed ID: 3219577 [TBL] [Abstract][Full Text] [Related]
11. Developmental and regional changes of mRNA for a cerebellar protein (spot 35) in the rat brain. Yamakuni T; Kuwano R; Araki K; Usui H; Inoue Y; Takahashi Y J Neurochem; 1988 Jan; 50(1):282-4. PubMed ID: 2826687 [TBL] [Abstract][Full Text] [Related]
12. Release of cholecystokinin-like immunoreactivity in the frontal cortex of conscious rats as assessed by transcerebral microdialysis: effects of different depolarizing stimuli. Vallebuona F; Paudice P; Raiteri M J Neurochem; 1993 Aug; 61(2):490-5. PubMed ID: 8336136 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of NMDA receptor (NMDAR1) mRNA levels in the adult and developing rat CNS. Franklin SO; Elliott K; Zhu YS; Wahlestedt C; Inturrisi CE Brain Res Mol Brain Res; 1993 Jul; 19(1-2):93-100. PubMed ID: 7689684 [TBL] [Abstract][Full Text] [Related]
14. Effects of ketamine on the cholecystokinin, somatostatin, substance P, and thyrotropin releasing hormone in discrete regions of rat brain. Pongdhana K; Ogawa N; Hirose Y; Ono T; Kosaka F; Mori A Neurochem Res; 1987 Jan; 12(1):73-7. PubMed ID: 2437471 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of three glutamate receptor genes in developing rat brain: an in situ hybridization study. Pellegrini-Giampietro DE; Bennett MV; Zukin RS Proc Natl Acad Sci U S A; 1991 May; 88(10):4157-61. PubMed ID: 1851996 [TBL] [Abstract][Full Text] [Related]
16. Expression of the cholecystokinin gene in the neuron and paraneuron. Takahashi Y; Kuwano R; Usui H; Araki K; Hasegawa M; Suzuki Y Arch Histol Cytol; 1989; 52 Suppl():63-8. PubMed ID: 2510804 [TBL] [Abstract][Full Text] [Related]
17. Preprocholecystokinin mRNA in rat brain: regional expression includes thalamus. Voigt MM; Uhl GR Brain Res; 1988 Nov; 464(3):247-53. PubMed ID: 3208111 [TBL] [Abstract][Full Text] [Related]
18. Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10). Radu D; Tomkinson B; Zachrisson O; Weber G; de Belleroche J; Hirsch S; Lindefors N Brain Res; 2006 Aug; 1104(1):175-82. PubMed ID: 16822484 [TBL] [Abstract][Full Text] [Related]
19. Inhibition by 5-HT3 receptor antagonists of release of cholecystokinin-like immunoreactivity from the frontal cortex of freely moving rats. Raiteri M; Paudice P; Vallebuona F Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):111-4. PubMed ID: 8446179 [TBL] [Abstract][Full Text] [Related]
20. Regional differences in the development of cholecystokinin-like activity in rat brain. VarrĂ³ A; Bu'lock AJ; Williams RG; Dockray GJ Brain Res; 1983 Sep; 285(3):347-52. PubMed ID: 6313134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]